These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 27729088

  • 1. Target delineation and optimal radiosurgical dose for pituitary tumors.
    Minniti G, Osti MF, Niyazi M.
    Radiat Oncol; 2016 Oct 11; 11(1):135. PubMed ID: 27729088
    [Abstract] [Full Text] [Related]

  • 2. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution.
    Kong DS, Lee JI, Lim DH, Kim KW, Shin HJ, Nam DH, Park K, Kim JH.
    Cancer; 2007 Aug 15; 110(4):854-60. PubMed ID: 17599761
    [Abstract] [Full Text] [Related]

  • 3. Radiotherapy and radiosurgery for Cushing's disease.
    Minniti G, Brada M.
    Arq Bras Endocrinol Metabol; 2007 Nov 15; 51(8):1373-80. PubMed ID: 18209876
    [Abstract] [Full Text] [Related]

  • 4. Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function: an international multicenter study.
    Pomeraniec IJ, Xu Z, Lee CC, Yang HC, Chytka T, Liscak R, Martinez-Alvarez R, Martinez-Moreno N, Attuati L, Picozzi P, Kondziolka D, Mureb M, Bernstein K, Mathieu D, Maillet M, Ogino A, Long H, Kano H, Lunsford LD, Zacharia BE, Mau C, Tuanquin LC, Cifarelli C, Arsanious D, Hack J, Warnick RE, Strickland BA, Zada G, Chang EL, Speckter H, Patel S, Ding D, Sheehan D, Sheehan K, Kvint S, Buch LY, Haber AR, Shteinhart J, Vance ML, Sheehan JP.
    J Neurosurg; 2022 Mar 01; 136(3):813-821. PubMed ID: 34560630
    [Abstract] [Full Text] [Related]

  • 5. Stereotactic radiotherapy and radiosurgery for non-functioning and secreting pituitary adenomas.
    Minniti G, Clarke E, Scaringi C, Enrici RM.
    Rep Pract Oncol Radiother; 2016 Mar 01; 21(4):370-8. PubMed ID: 27330422
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Clinical Outcome of Hypofractionated Stereotactic Radiotherapy With CyberKnife Robotic Radiosurgery for Perioptic Pituitary Adenoma.
    Puataweepong P, Dhanachai M, Hansasuta A, Dangprasert S, Swangsilpa T, Sitathanee C, Jiarpinitnun C, Vitoonpanich P, Yongvithisatid P.
    Technol Cancer Res Treat; 2016 Dec 01; 15(6):NP10-NP15. PubMed ID: 26424501
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Update on radiation therapy in patients with Cushing's disease.
    Tritos NA, Biller BM.
    Pituitary; 2015 Apr 01; 18(2):263-8. PubMed ID: 25359445
    [Abstract] [Full Text] [Related]

  • 13. Treatment of pituitary tumors: radiation.
    Mondok A, Szeifert GT, Mayer A, Czirják S, Gláz E, Nyáry I, Rácz K.
    Endocrine; 2005 Oct 01; 28(1):77-85. PubMed ID: 16311413
    [Abstract] [Full Text] [Related]

  • 14. Repeat stereotactic radiosurgery for Cushing's disease: outcomes of an international, multicenter study.
    Mehta GU, Ding D, Gupta A, Kano H, Sisterson ND, Martinez-Moreno N, Kršek M, Yang HC, Lee CC, Liščák R, Martinez-Alvarez R, Lunsford LD, Vance ML, Sheehan JP.
    J Neurooncol; 2018 Jul 01; 138(3):519-525. PubMed ID: 29500664
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Radiotherapy and Mortality in Pituitary Adenomas.
    González-Virla B, Vargas-Ortega G, Romero-Gameros CA.
    Arch Med Res; 2023 Dec 01; 54(8):102900. PubMed ID: 37940504
    [Abstract] [Full Text] [Related]

  • 17. Effect of distance from target on hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
    Ironside N, Snyder H, Xu Z, Schlesinger D, Chen CJ, Vance ML, Hong GK, Jane JA, Sheehan JP.
    J Neurooncol; 2022 May 01; 158(1):41-50. PubMed ID: 35461378
    [Abstract] [Full Text] [Related]

  • 18. Long-term radiographic and endocrinological outcomes of stereotactic radiosurgery for recurrent or residual nonfunctioning pituitary adenomas.
    Shaaban A, Dumot C, Mantziaris G, Dayawansa S, Peker S, Samanci Y, Nabeel AM, Reda WA, Tawadros SR, Abdel Karim K, El-Shehaby AMN, Emad Eldin RM, Ragab Abdelsalam A, Liscak R, May J, Mashiach E, De Nigris Vasconcellos F, Bernstein K, Kondziolka D, Speckter H, Mota R, Brito A, Bindal SK, Niranjan A, Lunsford LD, Benjamin CG, Almeida T, Mao JZ, Mathieu D, Tourigny JN, Tripathi M, Palmer JD, Matsui J, Crooks J, Wegner RE, Shepard MJ, Sheehan JP.
    J Neurosurg; 2024 Sep 01; 141(3):773-780. PubMed ID: 38518285
    [Abstract] [Full Text] [Related]

  • 19. Cushing's disease: a single centre's experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy.
    Wilson PJ, Williams JR, Smee RI.
    J Clin Neurosci; 2014 Jan 01; 21(1):100-6. PubMed ID: 24074805
    [Abstract] [Full Text] [Related]

  • 20. Biological Effective Dose as a Predictor of Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis and Cohort Study of Patients Treated Using Contemporary Techniques.
    Graffeo CS, Perry A, Link MJ, Brown PD, Young WF, Pollock BE.
    Neurosurgery; 2021 Mar 15; 88(4):E330-E335. PubMed ID: 33469668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.